Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology.
Saved in:
| Title: | Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology. |
|---|---|
| Authors: | Goje, Iacob-Daniel1,2 (AUTHOR), Goje, Greta-Ionela2,3 (AUTHOR) barbulescu.greta@umft.ro, Ordodi, Valentin Laurențiu3,4,5,6 (AUTHOR), Ciobotaru, Valentina Gabriela1,2,4 (AUTHOR), Ivan, Vlad Sabin1,2,5 (AUTHOR), Buzaș, Roxana1,2,6 (AUTHOR), Tunea, Oana1,2 (AUTHOR), Bojin, Florina2,5,6 (AUTHOR), Lighezan, Daniel-Florin1,2,3 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). May2025, Vol. 18 Issue 5, p681. 26p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
